Archive: 26/04/2018
Biomarkers and efficacy of vaccine responses among patients treated with new MS drug
In March 2017, the U.S. Food and Drug Administration approved ocrelizumab as the first treatment for both relapsing (RMS) and progressive forms of multiple sclerosis (MS), a genetic disease that afflicts approximately 400,000 ...
Apr 26, 2018
Who is using guns for suicide?
The average profile of an American using a gun for suicide is a married, white male over the age of 50 who is experiencing deteriorating health.
Apr 26, 2018